ABOUT

pic

MISSION

1 out of 4 persons over 65 year-old are living with Alzheimer’s and other dementias, but no effective treatment is available today.
Our mission is to serve people living with neurodegenerative disorders to maintain and improve their QOL through development of innovative medicine.

世界中で認知症に悩む皆さまのQOL維持と回復に貢献することを目的に、
イノベーションを治療薬の開発および実用化に繋げていきます。

TEAM

pic

Toru Kumagai, Ph.D.
熊谷 徹

CEO, Founder
・Marketing director for new business at GE Healthcare
・Global project leader at Astellas Pharma

pic

Takami Tomiyama, Ph.D.
富山 貴美

CSO, Co-Founder
・Research Professor in Translational Neuroscience at Osaka City University Graduate School of Medicine
・2017 – Out-licensed anti-tau antibody, co-developed with Teijin Pharma
・2010 – Developed Aβ oligomer model mouse

pagetop
S